<DOC>
	<DOCNO>NCT01220245</DOCNO>
	<brief_summary>In multicentre Randomized Clinical Trial , heparin-bonded endoluminal bypass compare surgical venous femoro-popliteal bypass , base non-inferiority principle patency . Besides equal patency , improve quality life expect . Recruitment take first two year patient follow five year . Patients indication surgical bypass , classify category 3-6 &gt; 50 % stenosis occlusion SFA &gt; /=10 cm length include . At least one crural artery patent without significant lesion .</brief_summary>
	<brief_title>SuperB Trial : SUrgical Versus PERcutaneous Bypass</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Age 18 year Informed consent Novo stenosis , restenosis &gt; 50 % occlusion native SFA , &gt; 10cm length Patent popliteal artery upper margin patella trifurcation Diameter native SFA popliteal artery 5.07.5 mm Indication surgical bypass Distal runoff least one crural artery without significant stenosis Anklebrachial index ( ABI ) rest &lt; 0.8 study limb prior procedure Patient unsuitable administration contrast agent Pregnancy Dementia alter mental status would prohibit give conscious inform consent Need adjunctive major surgical vascular procedure within one month Untreated flowlimiting aortoiliac occlusive disease Perioperative unsuccessful ipsilateral percutaneous vascular procedure treat inflow disease prior enrollment Femoral popliteal aneurysm target vessel Nonarthrotic disease result occlusion ( e.g . embolism , Buerger 's disease , vasculitis ) Severe medical comorbidities ( untreated CAD/CHF , severe COPD , metastatic malignancy , dementia etc . ) medical condition would preclude compliance study protocol Major distal amputation ( transmetatarsal ) study limb Any previously know coagulation disorder , include hypercoagulability Contraindication anticoagulation antiplatelet therapy Known allergy stent/stentgraft component History prior lifethreatening reaction contrast agent Patients know hypersensitivity heparin , include patient previous incidence heparininduced thrombocytopenia ( HIT ) type II Planned surgical procedure major amputation occur enrollment patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>endoluminal</keyword>
	<keyword>surgical</keyword>
	<keyword>bypass</keyword>
	<keyword>patency</keyword>
	<keyword>quality life</keyword>
	<keyword>multicentre</keyword>
	<keyword>RCT</keyword>
	<keyword>superficial femoral artery</keyword>
	<keyword>vascular patency</keyword>
</DOC>